Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Smirnova, E., Griparic, L., Shurland, D
Eli Lilly reported these results in mid-2025, and the retatrutide availability timeline now points toward potential FDA approval no earlier than 2027, as additional phase 3 trials continue
16 Prime Lab PeptidesResearch-grade peptides supplier purity specifications and certificates of analysis
Frequently Asked Questions How does National Science Labs describe Cagrilintide Peptide in the catalog
US$ 21.70
US$ 20.97
US$ 20.02
US$ 23.67
US$ 25.84
US$ 27.24
US$ 26.58
US$ 21.31
US$ 27.29
